IBD's Three Best ESG Companies In Eight Industry Categories For 2022Investors Business Daily • 10/24/22
European Commission Expands Merck's VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Indication to Include Infants, Children and AdolescentsBusiness Wire • 10/24/22
Merck's PREVYMIS™ Demonstrates Efficacy in Phase 3 Study for Prevention of Cytomegalovirus Disease in Adults After Kidney TransplantationBusiness Wire • 10/22/22
Merck Stock In Bullish Setup Ahead Of Q3 Results; Apple Leads FAANG Earnings BarrageInvestors Business Daily • 10/21/22
Kineta Announces Clinical Collaboration with Merck to Evaluate KVA12123 in Combination with KEYTRUDA® (pembrolizumab) in Cancer Patients with Advanced Solid TumorsGlobeNewsWire • 10/17/22
Merck And Moderna Move Forward With Melanoma Vaccine - There's A Case For Backing BothSeeking Alpha • 10/13/22
Moderna and Merck ink US$250mln deal to develop world's first cancer vaccineProactive Investors • 10/13/22
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccineBusiness Insider • 10/12/22
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patientsCNBC • 10/12/22
Moderna Surges As Merck Inks Deal To Co-Develop Personalized Cancer Vaccine TreatmentInvestors Business Daily • 10/12/22
8 Goldman Sachs Conviction List Dividend Stocks May Be the Safest Q4 Plays Now24/7 Wall Street • 10/12/22
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer VaccineAccesswire • 10/12/22
3 Dividend Stocks in Warren Buffett's Secret Portfolio Most Likely to Soar in Q4The Motley Fool • 10/12/22